4//SEC Filing
Aker Christopher Ray 4
Accession 0000950170-25-011849
CIK 0001505512other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:00 PM ET
Size
5.4 KB
Accession
0000950170-25-011849
Insider Transaction Report
Form 4
Aker Christopher Ray
Sr. VP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2025-01-30+487,500→ 487,500 totalExercise: $1.00Exp: 2035-01-29→ Common Stock (487,500 underlying)
Footnotes (1)
- [F1]The stock option commenced vesting on January 1, 2025 and will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001762611
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:00 PM ET
- Size
- 5.4 KB